TITLE

HPDI Table of Contents Vol. 13, No. 3, 2014

PUB. DATE
October 2014
SOURCE
Digestive Surgery;Oct2014, Vol. 31 Issue 3, p243
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available
ACCESSION #
98952505

 

Related Articles

  • Neutrophil-lymphocyte rations may predict HCC recurrence in liver transplant recipients.  // Hem/Onc Today;11/10/2012, Vol. 13 Issue 21, p23 

    The article reports on the results of a study concerning the rate of recurrence on patients with hepatocellular carcinoma who had neutrophil-lymphocyte ratios of 4 or greater following a liver transplant.

  • Longer transplant waits for HCC patients may be beneficial.  // Hem/Onc Today;12/10/2013, Vol. 14 Issue 23, p23 

    The article discusses a research study which suggested the benefit of longer transplant waits for patients with hepatocellular carcinoma (HCC), presented at The Liver Meeting held in Washington on November 1-5, 2013.

  • HBPD Table of Contents, Vol. 16, No. 6, 2017.  // Digestive Surgery;Feb2018, Vol. 35 Issue 2, p179 

    No abstract available.

  • OATP 1B1/1B3 expression in hepatocellular carcinomas treated with orthotopic liver transplantation. Vasuri, Francesco; Golfieri, Rita; Fiorentino, Michelangelo; Capizzi, Elisa; Renzulli, Matteo; Pinna, Antonio; Grigioni, Walter; D'Errico-Grigioni, Antonia; Pinna, Antonio D; Grigioni, Walter F // Virchows Archiv;Aug2011, Vol. 459 Issue 2, p141 

    The organic anion transporter peptides (OATP) 1B1 and 1B3 are hepatocytic-specific transporters determinant for the uptake of the contrast media Gd-EOB-DTPA during magnetic resonance, but variably lost in hepatocellular carcinoma (HCC). Here, we studied a series of HCCs from livers that...

  • Surgical aspects of liver disease.  // GP: General Practitioner;4/7/2003, p60 

    This article focuses on the recommendations made by physician Keith Barnard on various web pages at gponline.com. The web site addresswww.livercancer.com/index.html is from the Liver Cancer Network, a project supported by Allgheny General Hospital(General Hospital) in Pennsylvania. the web site...

  • O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantation. Zhu, Qianqian; Zhou, Lin; Yang, Zhe; Lai, Mingchun; Xie, Haiyang; Wu, Liming; Xing, Chunyang; Zhang, Feng; Zheng, Shusen // Medical Oncology;Jun2012, Vol. 29 Issue 2, p985 

    O-linked-ß-N-acetylglucosamine (O-GlcNAc) modification is a crucial post-translational modification. The enzymes responsible for the addition and removal of O-GlcNAc have been identified as O-GlcNAc transferase (OGT) and O-GlcNAcase (OGA). In this study, O-GlcNAcylation level was examined in...

  • Hepatocellular carcinoma. Ezaki, T. // BMJ: British Medical Journal (International Edition);1/25/92, Vol. 304 Issue 6821, p196 

    Focuses on hepatocellular carcinoma in Japan. Responsibility of the disease for at least one million death a year; Consideration of five year survival rate after surgical resection; Failure of the results of liver transplantation for the disease.

  • A Fair Chance for Everyone: Total Tumor Volume as a Selection Tool in Liver Transplantation for Hepatocellular Carcinoma. Pinto-Marques, Hugo; Silva, Silvia; Sobral, Mafalda; Perdigoto, Rui; Martins, Américo; Barroso, Eduardo // Digestive Surgery;Oct2018, Vol. 35 Issue 6, p539 

    Total tumor volume (TTV) has been proposed as a more accurate means of selecting patients for liver transplantation (LT) due to hepatocellular carcinoma (HCC). We aim to analyze the role of TTV in a population with a short waiting time on list. Methods: Analysis of a prospective database of...

  • HBPD Table of Contents Vol. 17, Nr. 4, 2018.  // Digestive Surgery;Dec2018, Vol. 36 Issue 1, p93 

    No abstract available.

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics